
Mary M. Barna, PharmD
Advertisement
Articles by Mary M. Barna, PharmD


Alzheimer's disease represents a mounting public health problem and clinicians need a strong understanding of both the disease and its various treatment modalities.

When discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.
Advertisement
Latest Updated Articles
Managing Opioid- Induced ConstipationPublished: September 15th 2009 | Updated:
Alzheimer's Disease: Slowing Down the CoursePublished: March 1st 2009 | Updated:
Overactive Bladder Disease: Overcoming the Urge to GoPublished: January 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Daratumumab Boosts Depth and Durability of Response After ASCT, Offering Clear Guidance for Pharmacist Counseling
3
ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants
4
American Cancer Society Updates Cervical Cancer Screening Guidelines to Include Self-Collection for HPV Testing
5





